Based on a recent study in a rat glaucoma model, Zhou et al. suggested that α2-AR activation hyperpolarizes RGCs by improving the γ-aminobutyric acid (GABA) receptor response to spontaneous and elicited GABA release, thus reducing the risk for excitotoxicity and RGC injury [167]. The gene discussed is ADORA2A; the disease is glaucoma.